Document Detail


Increased prevalence of cardiovascular complications in women with furosemide resistant essential hypertension.
MedLine Citation:
PMID:  8512666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with essential hypertension (n = 2969) who had not been taking any blood pressure medication for longer than 1 week were classified as furosemide-sensitive (FS) if their diastolic BP after furosemide fell > or = 10% and furosemide-resistant (FR) if it fell less than that. The FS group was significantly (P < or = .05) older, and had higher blood pressure than the FR group. In patients over age 50, the prevalence of cardiovascular complications (myocardial infarction, stroke, angina, congestive heart failure, and intermittent claudication) in the FR group (12.3%) was significantly (P = .0039) more than in the FS group for all patients, and especially for women (P = .0053). This was not explained by plasma renin activity, plasma norepinephrine, obesity index, cholesterol, blood sugar, or smoking history, and was associated in the FR group with a lower BP. This study characterizes the furosemide response of BP in hypertensive subjects and demonstrates an increased prevalence of cardiovascular complications in women over age 50 in the furosemide resistant group.
Authors:
G H Anderson; N Newman-Palmer; N Blakeman; D H Streeten
Related Documents :
10679506 - Attenuation of the "white-coat effect" by antihypertensive treatment and regression of ...
18059216 - New evidence confirms risks associated with prehypertension and benefits of therapeutic...
20409946 - Baroreflex stimulation: a novel treatment option for resistant hypertension.
15096906 - Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine...
2221586 - Endogenous opioids modulate the increase in ventilatory output and dyspnea during sever...
759066 - Bromocriptine inhibits norepinephrine release.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of hypertension     Volume:  6     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1993 May 
Date Detail:
Created Date:  1993-07-21     Completed Date:  1993-07-21     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  418-21     Citation Subset:  IM    
Affiliation:
Department of Medicine, SUNY-HSC, Syracuse 13210.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure / drug effects
Cardiovascular Diseases / epidemiology,  etiology*
Drug Resistance
Female
Furosemide / therapeutic use*
Humans
Hypertension / complications*,  drug therapy*
Male
Middle Aged
Prevalence
Regression Analysis
Sex Characteristics*
Grant Support
ID/Acronym/Agency:
HL 26748/HL/NHLBI NIH HHS; RR229/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
54-31-9/Furosemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ionic basis of hypertension in diabetes mellitus. Role of hyperglycemia.
Next Document:  Impact of diabetes on sodium-lithium countertransport in pregnancy-induced hypertension.